Triazoxins: Novel nucleosides with anti-Giardia activity

Praveen K. Pogula; Atasi De Chatterjee; Miguel Chi; Harrison W. VanKoten; Siddhartha Das; Steven E. Patterson

doi:10.1016/j.bmcl.2020.127175

Triazoxins: Novel nucleosides with anti-Giardia activity

Praveen K. Pogula, Atasi De Chatterjee, Miguel Chi, Harrison W. VanKoten, Siddhartha Das, Steven E. Patterson

Center for Drug Design

Research output: Contribution to journal › Article › peer-review

Abstract

Novel nucleoside analogues named “triazoxins” were synthesized. Of these, two analogues were found to be highly effective against Giardia lamblia, an intestinal parasite and a major cause of waterborne infection, worldwide. While compound 7 reduced the growth of trophozoites in culture (IC₅₀, ~5 μM), compound 21 blocked the in vitro cyst production (IC₅₀ ~5 μM). Compound 21 was also effective against trophozoites (IC₅₀, ~36 μM). A third analogue (compound 8) was effective against both trophozoites (IC₅₀, ~36 μM) and cysts (IC₅₀, ~20 μM) although at higher concentration. Thus triazoxin analogues are unique and exhibit morphology (i.e., trohozoites or cysts) -specific effects against Giardia.

Original language	English (US)
Article number	127175
Journal	Bioorganic and Medicinal Chemistry Letters
Volume	30
Issue number	12
DOIs	https://doi.org/10.1016/j.bmcl.2020.127175
State	Published - Jun 15 2020

Bibliographical note

Funding Information:
We thank the Center for Drug Design, and NIH- NIAID grant 1R21AI138061 for funding this project. Cellular experiments were carried out in the Border Biomedical Research Center (BBRC) core Facility at the University of Texas at El Paso supported by a grant ( G12MD0075592 ) from the NIMHD (NIH). ADC and SD were supported partly by a grant ( R01AI095667 ) from the NIH ( NIAID ). MC was supported by NIH-RISE Grant 5R25GM069621 .

Funding Information:
We thank the Center for Drug Design, and NIH-NIAID grant 1R21AI138061 for funding this project. Cellular experiments were carried out in the Border Biomedical Research Center (BBRC) core Facility at the University of Texas at El Paso supported by a grant (G12MD0075592) from the NIMHD (NIH). ADC and SD were supported partly by a grant (R01AI095667) from the NIH (NIAID). MC was supported by NIH-RISE Grant 5R25GM069621.

Keywords

Anti-giardiasis
Cyst
Giardia
Phosphonoxin
Triazoxin
Trophozoite

Access

10.1016/j.bmcl.2020.127175

Fingerprint Dive into the research topics of 'Triazoxins: Novel nucleosides with anti-Giardia activity'. Together they form a unique fingerprint.

Cite this

@article{ac2a7e06280b43319a7b061415ef1a5b,

title = "Triazoxins: Novel nucleosides with anti-Giardia activity",

abstract = "Novel nucleoside analogues named “triazoxins” were synthesized. Of these, two analogues were found to be highly effective against Giardia lamblia, an intestinal parasite and a major cause of waterborne infection, worldwide. While compound 7 reduced the growth of trophozoites in culture (IC50, ~5 μM), compound 21 blocked the in vitro cyst production (IC50 ~5 μM). Compound 21 was also effective against trophozoites (IC50, ~36 μM). A third analogue (compound 8) was effective against both trophozoites (IC50, ~36 μM) and cysts (IC50, ~20 μM) although at higher concentration. Thus triazoxin analogues are unique and exhibit morphology (i.e., trohozoites or cysts) -specific effects against Giardia.",

keywords = "Anti-giardiasis, Cyst, Giardia, Phosphonoxin, Triazoxin, Trophozoite",

author = "Pogula, {Praveen K.} and {De Chatterjee}, Atasi and Miguel Chi and VanKoten, {Harrison W.} and Siddhartha Das and Patterson, {Steven E.}",

note = "Funding Information: We thank the Center for Drug Design, and NIH- NIAID grant 1R21AI138061 for funding this project. Cellular experiments were carried out in the Border Biomedical Research Center (BBRC) core Facility at the University of Texas at El Paso supported by a grant ( G12MD0075592 ) from the NIMHD (NIH). ADC and SD were supported partly by a grant ( R01AI095667 ) from the NIH ( NIAID ). MC was supported by NIH-RISE Grant 5R25GM069621 . Funding Information: We thank the Center for Drug Design, and NIH-NIAID grant 1R21AI138061 for funding this project. Cellular experiments were carried out in the Border Biomedical Research Center (BBRC) core Facility at the University of Texas at El Paso supported by a grant (G12MD0075592) from the NIMHD (NIH). ADC and SD were supported partly by a grant (R01AI095667) from the NIH (NIAID). MC was supported by NIH-RISE Grant 5R25GM069621.",

year = "2020",

month = jun,

day = "15",

doi = "10.1016/j.bmcl.2020.127175",

language = "English (US)",

volume = "30",

journal = "Bioorganic and Medicinal Chemistry Letters",

issn = "0960-894X",

publisher = "Elsevier Limited",

number = "12",

}

TY - JOUR

T1 - Triazoxins

T2 - Novel nucleosides with anti-Giardia activity

AU - Pogula, Praveen K.

AU - De Chatterjee, Atasi

AU - Chi, Miguel

AU - VanKoten, Harrison W.

AU - Das, Siddhartha

AU - Patterson, Steven E.

N1 - Funding Information: We thank the Center for Drug Design, and NIH- NIAID grant 1R21AI138061 for funding this project. Cellular experiments were carried out in the Border Biomedical Research Center (BBRC) core Facility at the University of Texas at El Paso supported by a grant ( G12MD0075592 ) from the NIMHD (NIH). ADC and SD were supported partly by a grant ( R01AI095667 ) from the NIH ( NIAID ). MC was supported by NIH-RISE Grant 5R25GM069621 . Funding Information: We thank the Center for Drug Design, and NIH-NIAID grant 1R21AI138061 for funding this project. Cellular experiments were carried out in the Border Biomedical Research Center (BBRC) core Facility at the University of Texas at El Paso supported by a grant (G12MD0075592) from the NIMHD (NIH). ADC and SD were supported partly by a grant (R01AI095667) from the NIH (NIAID). MC was supported by NIH-RISE Grant 5R25GM069621.

PY - 2020/6/15

Y1 - 2020/6/15

N2 - Novel nucleoside analogues named “triazoxins” were synthesized. Of these, two analogues were found to be highly effective against Giardia lamblia, an intestinal parasite and a major cause of waterborne infection, worldwide. While compound 7 reduced the growth of trophozoites in culture (IC50, ~5 μM), compound 21 blocked the in vitro cyst production (IC50 ~5 μM). Compound 21 was also effective against trophozoites (IC50, ~36 μM). A third analogue (compound 8) was effective against both trophozoites (IC50, ~36 μM) and cysts (IC50, ~20 μM) although at higher concentration. Thus triazoxin analogues are unique and exhibit morphology (i.e., trohozoites or cysts) -specific effects against Giardia.

AB - Novel nucleoside analogues named “triazoxins” were synthesized. Of these, two analogues were found to be highly effective against Giardia lamblia, an intestinal parasite and a major cause of waterborne infection, worldwide. While compound 7 reduced the growth of trophozoites in culture (IC50, ~5 μM), compound 21 blocked the in vitro cyst production (IC50 ~5 μM). Compound 21 was also effective against trophozoites (IC50, ~36 μM). A third analogue (compound 8) was effective against both trophozoites (IC50, ~36 μM) and cysts (IC50, ~20 μM) although at higher concentration. Thus triazoxin analogues are unique and exhibit morphology (i.e., trohozoites or cysts) -specific effects against Giardia.

KW - Anti-giardiasis

KW - Cyst

KW - Giardia

KW - Phosphonoxin

KW - Triazoxin

KW - Trophozoite

UR - http://www.scopus.com/inward/record.url?scp=85083390739&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85083390739&partnerID=8YFLogxK

U2 - 10.1016/j.bmcl.2020.127175

DO - 10.1016/j.bmcl.2020.127175

M3 - Article

C2 - 32327222

AN - SCOPUS:85083390739

VL - 30

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

SN - 0960-894X

IS - 12

M1 - 127175

ER -